297 related articles for article (PubMed ID: 18287570)
1. Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy.
Verny C; Loiseau D; Scherer C; Lejeune P; Chevrollier A; Gueguen N; Guillet V; Dubas F; Reynier P; Amati-Bonneau P; Bonneau D
Neurology; 2008 Mar; 70(13 Pt 2):1152-3. PubMed ID: 18287570
[No Abstract] [Full Text] [Related]
2. Mitochondrial DNA content is decreased in autosomal dominant optic atrophy.
Kim JY; Hwang JM; Ko HS; Seong MW; Park BJ; Park SS
Neurology; 2005 Mar; 64(6):966-72. PubMed ID: 15781809
[TBL] [Abstract][Full Text] [Related]
3. Hereditary optic neuropathies share a common mitochondrial coupling defect.
Chevrollier A; Guillet V; Loiseau D; Gueguen N; de Crescenzo MA; Verny C; Ferre M; Dollfus H; Odent S; Milea D; Goizet C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P
Ann Neurol; 2008 Jun; 63(6):794-8. PubMed ID: 18496845
[TBL] [Abstract][Full Text] [Related]
4. Optic mitochondriopathies.
Chinnery PF; Griffiths PG
Neurology; 2005 Mar; 64(6):940-1. PubMed ID: 15781804
[No Abstract] [Full Text] [Related]
5. Myelin, mitochondria, and autoimmunity: what's the connection?
Carelli V; Bellan M
Neurology; 2008 Mar; 70(13 Pt 2):1075-6. PubMed ID: 18362271
[No Abstract] [Full Text] [Related]
6. A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.
Liguori M; La Russa A; Manna I; Andreoli V; Caracciolo M; Spadafora P; Cittadella R; Quattrone A
J Neurol; 2008 Jan; 255(1):127-9. PubMed ID: 18204809
[No Abstract] [Full Text] [Related]
7. OPA1-associated disorders: phenotypes and pathophysiology.
Amati-Bonneau P; Milea D; Bonneau D; Chevrollier A; Ferré M; Guillet V; Gueguen N; Loiseau D; de Crescenzo MA; Verny C; Procaccio V; Lenaers G; Reynier P
Int J Biochem Cell Biol; 2009 Oct; 41(10):1855-65. PubMed ID: 19389487
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
[TBL] [Abstract][Full Text] [Related]
9. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.
Lodi R; Tonon C; Valentino ML; Iotti S; Clementi V; Malucelli E; Barboni P; Longanesi L; Schimpf S; Wissinger B; Baruzzi A; Barbiroli B; Carelli V
Ann Neurol; 2004 Nov; 56(5):719-23. PubMed ID: 15505825
[TBL] [Abstract][Full Text] [Related]
10. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.
Amati-Bonneau P; Guichet A; Olichon A; Chevrollier A; Viala F; Miot S; Ayuso C; Odent S; Arrouet C; Verny C; Calmels MN; Simard G; Belenguer P; Wang J; Puel JL; Hamel C; Malthièry Y; Bonneau D; Lenaers G; Reynier P
Ann Neurol; 2005 Dec; 58(6):958-63. PubMed ID: 16240368
[TBL] [Abstract][Full Text] [Related]
11. The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.
Sarzi E; Angebault C; Seveno M; Gueguen N; Chaix B; Bielicki G; Boddaert N; Mausset-Bonnefont AL; Cazevieille C; Rigau V; Renou JP; Wang J; Delettre C; Brabet P; Puel JL; Hamel CP; Reynier P; Lenaers G
Brain; 2012 Dec; 135(Pt 12):3599-613. PubMed ID: 23250881
[TBL] [Abstract][Full Text] [Related]
12. Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
Baris O; Delettre C; Amati-Bonneau P; Surget MO; Charlin JF; Catier A; Derieux L; Guyomard JL; Dollfus H; Jonveaux P; Ayuso C; Maumenee I; Lorenz B; Mohammed S; Tourmen Y; Bonneau D; Malthièry Y; Hamel C; Reynier P
Hum Mutat; 2003 Jun; 21(6):656. PubMed ID: 14961560
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial disorder with OPA1 mutation lacking optic atrophy.
Milone M; Younge BR; Wang J; Zhang S; Wong LJ
Mitochondrion; 2009 Jul; 9(4):279-81. PubMed ID: 19303950
[TBL] [Abstract][Full Text] [Related]
14. The G401D mutation of OPA1 causes autosomal dominant optic atrophy and hearing loss in a Chinese family.
Ke T; Nie SW; Yang QB; Liu JP; Zhou LN; Ren X; Liu JY; Wang Q; Liu MG
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):481-5. PubMed ID: 17029191
[TBL] [Abstract][Full Text] [Related]
15. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.
Payne M; Yang Z; Katz BJ; Warner JE; Weight CJ; Zhao Y; Pearson ED; Treft RL; Hillman T; Kennedy RJ; Meire FM; Zhang K
Am J Ophthalmol; 2004 Nov; 138(5):749-55. PubMed ID: 15531309
[TBL] [Abstract][Full Text] [Related]
16. Dominant optic atrophy, neuropathy, ataxia, white matter FLAIR hypersignals, middle cerebellar peduncule atrophy and asthenia in OPA1 mutation.
Magnin E; Allibert R; Berger E; Dollfus H; Rumbach L
Eur Neurol; 2012; 67(5):287. PubMed ID: 22472598
[No Abstract] [Full Text] [Related]
17. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
[TBL] [Abstract][Full Text] [Related]
18. Pseudodominant inheritance of spastic ataxia of Charlevoix-Saguenay.
Terracciano A; Foulds NC; Ditchfield A; Bunyan DJ; Crolla JA; Huang S; Santorelli FM; Hammans SR
Neurology; 2010 Apr; 74(14):1152-4. PubMed ID: 20368637
[No Abstract] [Full Text] [Related]
19. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis.
Olichon A; Landes T; Arnauné-Pelloquin L; Emorine LJ; Mils V; Guichet A; Delettre C; Hamel C; Amati-Bonneau P; Bonneau D; Reynier P; Lenaers G; Belenguer P
J Cell Physiol; 2007 May; 211(2):423-30. PubMed ID: 17167772
[TBL] [Abstract][Full Text] [Related]
20. Neuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction.
Roubertie A; Leboucq N; Picot MC; Nogue E; Brunel H; Le Bars E; Manes G; Angebault Prouteau C; Blanchet C; Mondain M; Chevassus H; Amati-Bonneau P; Sarzi E; Pagès M; Villain M; Meunier I; Lenaers G; Hamel CP
J Neurol Sci; 2015 Feb; 349(1-2):154-60. PubMed ID: 25641387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
